48
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Expression of p56lck in B-Cell Neoplasias

, , , &
Pages 551-562 | Accepted 30 Nov 1996, Published online: 01 Jul 2009

References

  • Chow L. M. L., Veillette A. The src and csk families of tyrosine protein kinases in hematopoietic cells. Sem. Immunol. 1995; 7: 207–226
  • Gacon G., Gisselbrecht S., Piau J. P., Boissel J. P., Tolle J., Fischer S. High level of tyrosine protein kinase in a murine lymphoma cell line induced by Moloney leukemia virus. EMBO J. 1982; 1: 1579–1583
  • Veillette A., Horak I. D., Bookman M. A., Bolen J. B. Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation. Mol. Cell. Biol. 1988; 8: 4353–4361
  • Hatakeyama M., Kono T., Kohayashi N., Kawahara A., Levin S. D., Perlmutter R. M., Taniguchi T. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science 1991; 252: 1523–1528
  • Cassatela M. A., AnegÓN I., Cuturi M. C., Griskey P., Trinchieri G., Perussia B. Fcy(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. J. Exp. Med. 1989; 169: 549–567
  • Taieb J., Vitte-Mony I., Auffredou M. T., Dorseuil O., Gacon G., Bertoglio J., Vazquez A. Regulation of p56lck kinase expression and control of DNA synthesis in activated human B lymphocytes. J. Biol. Chem. 1993; 268: 9169–9171
  • Veillette A., Foss F. M., Sausville E. A., Bolen J. B., Rosen N. Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. Oncogene Res. 1987; 1: 357–374
  • Sartor O., Gregory F. S., Templeton N. S., Pawar S., Perlmutter R. M., Rosen N. Selective expression of alternative lck mRNAs in human malignant cell lines. Mol. Cell. Biol. 1989; 99: 2983–2988
  • Brouns G. S., Devries E., Van Noesel C. J. M., Mason D. Y., Van Lier R. A. W., Borst J. The structure of the μ/pseudo light chain complex on the human pre-B cells is consistent with a function in signal transduction. Eur. J. Immunol. 1993; 23: 1088–1097
  • Adler H. T., Reynolds P. J., Kelley C. M., Sefton B. M. Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters. J. Virol. 1988; 62: 4113–4122
  • Casnellie J. E., Harrison M. L., Hellstrom K. E., Krebs E. G. A lymphoma cell line expressing elevated levels of tyrosine protein kinase activity. J. Biol. Chem. 1983; 258: 10738–10741
  • Abraham K. M., Levin S. D., Marth J. D., Forbush K. A., Perlmutter R. M. Thymic tumorigenesis induced by overexpression of p56lck. Proc. Natl. Acad. Sci. USA 1991; 88: 3977–3981
  • Marth J. D., Overell R. W., Meier K. E., Krebs E. G., Perlmutter R. M. Translational activation of the lck proto-oncogene. Nature 1988; 332: 171–173
  • Adler H. T., Sefton B. M. Generation and characterization of transforming variants of the lck tyrosine protein kinase. Oncogene 1992; 7: 1191–1199
  • Mayer K. M., Ansotegui I., Ballhausen W. G. The human lck cDNA clone YT16 is a transforming oncogene. Anticancer Res. 1992; 12: 485–488
  • Jücker M., Abts H., Eick D., Lenoir G. M., Tesch H. Over-expression of lck in Burkitt's lymphoma cell lines. Leukemia 1991; 5: 528–30
  • Abts H., JÜCker M., Diehl V., Tesch H. Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr. Leukemia Res. 1991; 15: 987–997
  • Lenoir G. M., Vuillaume M., Bonnardel C. The use of lymphomatous and lymphohlastoid cell lines in the study of Burkitt' s lymphoma. IARC Scientific Publication 1985; 59: 309–318
  • Tchou-Wong K. M., Weinstein I. B. Altered expression of protein kinase C, lck, and CD45 in a 12-O-tetradecanoylphorbol-13-acetate-dependent leukemic T-cell variant that expresses a high level of interleukin-2 receptor. Mol. Cell. Biol. 1992; 12: 394–401
  • Degiannis D., Hornung N., Luke-Gustites D., Raskova J., Raska K. IL-4 receptor expression by SAC-acti-vated B-lymphoctes: its role in B-cell proliferation and the effect of cyclospoiine (CsA), prednisolone and verapmil. Int. J. Immunopharmacol. 1993; 15: 829–32
  • Aoki Y., Isselbacher K. J., Cherayil B. J., Pillai S. Tyrosine phosphorylation of Blk and Fyn Src homol-ogy 2 domain-binding protein occurs in response to antigen-receptor ligation in B cells and constitutively, in pre-B cells. Proc. Natl. Acad. Sci. USA 1994; 91: 4204–8
  • Danielian S., Alcover A., Polissard L., Stefanescu M., Acuto O., Fischer S., Fagard R. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-indepen-dent and CD45-dependent activation of p56lck. Eur. J. Immunol. 1992; 22: 2915–2921
  • Danielian S., Fagard R., Boulet I., Fischer S. The retarded electrophoretic migration of p56lck induced by vanadate in lymphoma cells correlates with modified kinase activity. Biochimie 1990; 72: 315–322
  • Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
  • Danielian S., Fagard R., Alcover A., Acuto O., Fischer S. The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2. Eur. J. Immunol. 1989; 19: 2183–2189
  • Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a comman cis element recognized by a TPA-modulated fransacting factor. Cell 1987; 49: 729–739
  • Makover D., Cuddy M., Yum S., Bradley K., Alpers J., Sukhatme V., Reed J. C. Phorhol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line Jurkat. Oncogene 1991; 6: 455–460
  • Burckhardt A. L., Brunswick M., Bolen J. B., Mond J. J. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 1991; 88: 7410–7414
  • Campbell M.-A., Sefton B. M. Association between B-lymphocyte membrane immunoglobulin and multiple members of the src family of protein tyrosine kinases. Mol. Cell. 1992; 12: 2315–2321, Biol.
  • Cheah M. S., Ley T. J., Tronick S. R., Robbins K. C. fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Ban virus infection. Nature 1986; 319: 238–240
  • Wang F., Gregory C. D., Rowe M., Rickinson A. B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 1987; 84, 3452–3457.
  • Wang F., Gregory C., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E. Epstein-Barr virus latent membrane protein (LMPl) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA2 and LMPl cooperatively induce CD23. J. Virol. 1990; 64: 2309–2318
  • Miyazaki T., Liu Z. J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., Barsoumian E. L., Perlmutter R. M., Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation. Cell 1995; 81: 223–231
  • Van Oers N. S., Lilleen N., Weiss A. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 1996; 183: 1053–62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.